Oncolytics Biotech logo

Oncolytics Biotech Share Price (NASDAQ: ONCY)

$1.01

Live

Last updated on

Check the interactive Oncolytics Biotech Stock chart to analyse performance

Oncolytics Biotech stock performance

as on August 26, 2025 at 12:38 AM IST

  • Today's Low:$1.01
    Today's High:$1.02

    Day's Volatility :0.98%

  • 52 Weeks Low:$0.33
    52 Weeks High:$1.53

    52 Weeks Volatility :78.71%

Oncolytics Biotech Stock Returns

PeriodOncolytics Biotech IncIndex (Russel 2000)
3 Months
151.87%
0.0%
6 Months
41.5%
0.0%
1 Year
4.24%
0.0%
3 Years
-31.06%
-10.0%

Oncolytics Biotech Inc Key Stats

Check Oncolytics Biotech key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.01
Open
$1.03
Today's High
$1.02
Today's Low
$0.9804
Market Capitalization
$102.5M
Today's Volume
$476.3K
52 Week High
$1.53
52 Week Low
$0.3258
Revenue TTM
$0.0
EBITDA
$-30.9M
Earnings Per Share (EPS)
$-0.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-249.28%

Stock Returns calculator for Oncolytics Biotech Stock including INR - Dollar returns

The Oncolytics Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oncolytics Biotech investment value today

Current value as on today

₹1,08,459

Returns

₹8,459

(+8.46%)

Returns from Oncolytics Biotech Stock

₹4,124 (+4.12%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Oncolytics Biotech Stock

-56%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Oncolytics Biotech Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Oncolytics Biotech Inc

  • Name

    Holdings %

  • SEEDS INVESTOR LLC

    0.23%

  • International Assets Investment Management, LLC

    0.21%

  • Goldman Sachs Group Inc

    0.13%

  • Royal Bank of Canada

    0.07%

  • Geode Capital Management, LLC

    0.07%

  • Franklin Resources Inc

    0.07%

Analyst Recommendation on Oncolytics Biotech Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Oncolytics Biotech(by analysts ranked 0 to 5 stars)

Oncolytics Biotech Share Price Target

What analysts predicted

Upside of 355.22%

Target:

$4.60

Current:

$1.01

Oncolytics Biotech share price target is $4.60, a slight Upside of 355.22% compared to current price of $1.01 as per analysts' prediction.

Oncolytics Biotech Stock Insights

  • Price Movement

    In the last 3 months, ONCY stock has moved up by 141.4%
  • ONCY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 64.7%
  • ONCY vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 145.5%

Oncolytics Biotech Technicals Summary

Sell

Neutral

Buy

Oncolytics Biotech is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Oncolytics Biotech Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Oncolytics Biotech Inc logo
-7.34%
41.5%
4.24%
-31.06%
-42.61%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Oncolytics Biotech Inc

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.
Organization
Oncolytics Biotech
Employees
28
CEO
Mr. Jared Kelly J.D., L.L.M.
Industry
Health Technology

Key Management of Oncolytics Biotech Inc

NameTitle
Mr. Kirk J. Look C.A., CPA
Chief Financial Officer
Dr. Thomas C. Heineman M.D., Ph.D.
Chief Medical Officer
Ms. Allison Hagerman P.Eng., P.M.P.
Vice President of Product Development
Ms. Amy Goodowitz Levin B.S.N., R.N.
Vice President of Clinical Operations
Mr. Jared Kelly J.D., L.L.M.
CEO & Director
Jon Patton
Director of Investor Relations & Communication
Mr. Andrew P. Aromando
Chief Business Officer
Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.
Consultant

Important FAQs about investing in ONCY Stock from India :

What is Oncolytics Biotech share price today?

Oncolytics Biotech share price today is $1.01 as on . Oncolytics Biotech share today touched a day high of $1.02 and a low of $1.01.

What is the 52 week high and 52 week low for Oncolytics Biotech share?

Oncolytics Biotech share touched a 52 week high of $1.53 and a 52 week low of $0.33. Oncolytics Biotech stock price today i.e. is trending at $1.01, lower by 33.99% versus the 52 week high.

How to invest in Oncolytics Biotech Stock (ONCY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oncolytics Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oncolytics Biotech Shares that will get you 1.4851 shares as per Oncolytics Biotech share price of $1.01 per share as on August 26, 2025 at 12:38 AM IST.

What is the minimum amount required to buy Oncolytics Biotech Stock (ONCY) from India?

Indian investors can start investing in Oncolytics Biotech (ONCY) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Oncolytics Biotech stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Oncolytics Biotech share’s latest price of $1.01 as on August 26, 2025 at 12:38 AM IST, you will get 9.9010 shares of Oncolytics Biotech. Learn more about fractional shares .

What are the returns that Oncolytics Biotech has given to Indian investors in the last 5 years?

Oncolytics Biotech stock has given -42.61% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?